The Quarter is Over…And of course that means VC data
The venture capital investment numbers are out for the Q2 2012 (courtesy of NVCA & PwC). Last…
Walls and Fences – Biotechnology Analogy
After the Biotechnology Industry Organization (BIO) international convention last week, I spent the weekend…
Sometimes All You Need is a Little Attitude (Adjustment)
I had planned to write a themes and data follow up post for my…
Pharma Strategy Blog, AACR and Ribonucleases
The American Association for Cancer Research annual meeting has come and gone for 2012…
What do quarterly VC numbers tell us?
The venture capital investment numbers are out for the first quarter of 2012 (courtesy…
Learning from Shareholders
This week we held our annual meeting for shareholders of Quintessence (private company funded…
A Biotech Fable – The Crows and the Pitcher
In the old days, the birds didn’t worry about the narrow neck of the…
Dose – Only a Piece of the Puzzle
This week I put together a summary of some data from our ongoing clinical…
What is Success?
I’ve had the topic of “success” on my mind quite a bit recently because…
Venture Capital in Wisconsin – There Is Good News
This post started as an email to a group of friends who encouraged me…
Load More